MEDINET 2370

メディネット

Recent Updates

2023-09-14

Taiwanese regulatory authorities approve the provision of cancer immunocellular therapy using MEDINET's technology at a new medical facility

2023-09-12

Q3 FY09/23 report update

2023-09-04

Announcement regarding investment in kokoromil Co., Ltd.

Get in touch

Address:TRC Center Bldg, 9F 6-1-1 Heiwajima, Ota-ku Tokyo, Japan 143-0006

Website:https://www.medinet-inc.co.jp/english/ir/

Summary

Shifting from Immuno-Cell Therapy Total Support Service to the Contracted Cell Manufacturing Business; sale and development of cell medicinal products

Key dates

2010-09-30

Coverage initiation